POET Technologies: Between a $500 Million Lumilens Promise and a Mounting Legal Overhang

The optics specialist has raised nearly $830 million in equity over the past twelve months, with warrants that could inject another $661 million. It operates facilities in Singapore and Malaysia, employs more than 115 people worldwide, and has a stock that has fallen more than 54% from its May peak. For investors, the message from the June 26 virtual shareholder meeting was unmistakable: credibility now hinges on shipments, not on capital raises.

Chief executive Suresh Venkatesan laid out a three-pronged strategy dubbed the “Three Cs” — credibility, capacity, capability. The timetable is concrete. POET plans to begin its production ramp in the second half of 2026, including first volume deliveries to customers before year-end. To support that push, the company is investing roughly $50 million in new production equipment, also in the second half. Management describes the outlay as a forward-looking move to avoid falling short of anticipated demand. Wafer and optical engine assembly capacity is expected to expand roughly tenfold by 2027.

The most tangible demand signal remains the Lumilens agreement struck in May. That partner placed an initial order worth $50 million for EOI-based optical engines, with the potential to grow to more than $500 million over five years. Still, revenue and deliveries depend on successful development, qualification and scaling. Engineering samples from the joint programme are expected by the end of 2026, with a full production ramp for hyperscaler clients targeted for 2027.

Should investors sell immediately? Or is it worth buying POET Technologies?

Those operational milestones are unfolding against a backdrop of serious legal turbulence. Two law firms — DJS Law Group and Schall Law Firm — have filed class-action suits against the company, with the lead plaintiff deadline falling on Monday. The allegations centre on misleading statements about POET’s tax status as a passive foreign investment company (PFIC). In addition, the lawsuits accuse chief financial officer Thomas Mika of breaching confidential business agreements in an interview. The company has pushed back, announcing in April that it would help US shareholders mitigate any tax disadvantages for 2025 and stating it does not expect to be classified as a PFIC for the current year. The board has approved a move of domicile to the United States, though no final guarantee has been given.

The legal headache compounds an already difficult operational setback. In late April, Marvell Semiconductor cancelled all orders from POET’s subsidiary Celestial AI, alleging that the company had violated confidentiality agreements regarding supply data. The blow to commercialisation was severe. Management points to remaining customers, including a roughly $5 million order from another technology company, but the loss of Marvell’s business weighs heavily.

At the stock exchange, the uncertainty has left deep marks. Shares closed at €8.61, down about 22% on the week, and are trading roughly 54% below the 52-week high of €18.84 reached on May 15. On a year-to-date basis the stock still shows a gain of around 35%. The relative strength index sits at 41, and the annualised 30-day volatility is nearly 128% — a market that is jittery but not panicked.

The next few months will test whether POET can convert its hefty cash pile and ambitious targets into measurable results. Capital spending on equipment is due in the third quarter, first volume deliveries by year-end, and progress on the Lumilens timeline is critical. Meanwhile, the company must navigate the class-action lawsuits and find new, reliable orders to replace the Marvell business. For shareholders, the bet is that by late 2026 presentation language will have turned into hard revenue.

Ad

POET Technologies Stock: New Analysis - 30 June

Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated POET Technologies analysis...

en | CA73044W3021 | POET | boerse | 69656473 |